Sir, The suggestion by Debbas et al (1984; 51: 316-20) that prolongation of the QT interval correlates with plasma and myocardial concentrations in patients receiving long term oral trpatment may have important implications for patients treated with intravenous amiodarone. We have treated a selected group of patients with acute myocardial infarction with intravenous amiodarone as a bolus of 5 mg/kg followed by an infusion of 1000 mg over 24 hours. QTc intervals increased during the infusion in 11 of 12 subjects. The mean increase at the end of the 24 hours was 11% when the mean plasma concentration of amiodarone was 2*05 (range 0.9-4-0) mg/l and of the desethyl metabolite 0*23 (range 0-1-0.4) mg/l.
We conclude that serum amiodarone concentrations rise rapidly after intravenous administration, and this is associated with a lengthening of the-QT interval, which may indicate myocardial impregnation and an antiarrhythmic effect. The desethyl metabolite is found in low concentrations within this 24 hour period compared with the usual plasma concentrations achieved in patients receiving prolonged oral treatment and is unlikely to be a major factor in any acute drug effects. 
